GAPDH and cancer: Against GAPDH (1U8F), Nyctanthic acid also showed a competitive binding affinity (−113.841 kcal/mol) compared to β‐Glucogallin (−112.534) and Galuteolin (−117.778 kcal/mol), highlighting its comparable affinity toward this cancer‐related protein target.